Oberweis Asset Management »

Catalyst Pharmaceutical Partners shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.1M 458k 15.49
2024-03-31 $7.3M 458k 15.94
2023-12-31 $5.9M 349k 16.81
2023-09-30 $3.4M 294k 11.69
2023-06-30 $2.5M 183k 13.44
2023-03-31 $2.4M 147k 16.58
2022-12-31 $1.8M 97k 18.60

More positions owned by Oberweis Asset Management

Weatherford Intl Ordf (WFRD)
Constellium Se cl a (CSTM)
Sharkninja (SN)
Onto Innovation (ONTO)
Transmedics Group (TMDX)
Zeta Global Holdings Corp (ZETA)
Encompass Health Corp (EHC)
Credo Technology Group Holding (CRDO)
SkyWest (SKYW)
Clean Harbors (CLH)
Adma Biologics (ADMA)
Silicon Motion Technology (SIMO)
Camtek (CAMT)
Universal Display Corporation (OLED)
Oshkosh Corporation (OSK)

View all positions for Oberweis Asset Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Henderson Group
Royce & Associates
Northern Trust
Kennedy Capital Management
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners